Apogee Therapeutics Inc.

APGE

⚠ Showing the latest available close (Sep 3, 2026, 63 days ago). Our price provider hasn't published a newer EOD for this ticker yet. Price-dependent metrics (P/E, P/FCF, yield) may not reflect current market conditions.

We are a clinical stage biotechnology company advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the largest inflammatory and immunology ( I&I ) markets, including for the treatment of atopic dermatitis ( AD ), asthma, eosinophilic esophagitis ( EoE ), chronic obstructive pulmonary disease ( COPD ), and other I&I indications. Our antibody …

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$10.19B

EPS-$4.34

P/E-31.12

P/FCF-41.78

EV/EBITDA-28.12

FCF Yield–

Div. Yield–

Net Debt/FCF4.0x

Apogee Therapeutics Inc. intrinsic value

52-Week Range

$54.71$135.08

Profitability & Returns

TTM as of 2026-06 · YoY vs prior year · ROIC = NOPAT / invested capital

Revenue

N/A

Net Income (TTM)

-$294M

▼ -40.5% YoY

Op. Margin

–

ROIC

–

Cash Flow & Balance Sheet

FCF = operating cash flow + capex · Net debt = total debt − cash · Balance sheet from latest filing

FCF (TTM)

-$244M

▼ -35.0% YoY

Op. Cash Flow (TTM)

-$244M

▼ -32.9% YoY

Net Debt

-$965M

Net Cash Position

Cash & Equiv.

$972M

Continue Research

Quality Scorecard

Is this a high-quality business?

Dividends

Payout safety and growth

Intrinsic Value

What is it worth?

Financials

Full income, cash flow, balance sheet

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with APGE

CompareIntrinsic value

ENTXEntera Bio Ltd.

$3.11+1.97%20

ELOXEloxx Pharmaceuticals, Inc.

$12.74-1.39%20

CMPXCompass Therapeutics Inc.

$0.76+1.33%10

SABSSab Biotherapeutics Inc.

$3.18+1.92%19

ARTVArtiva Biotherapeutics Inc.

$4.22+0.48%10

GLUEMonte Rosa Therapeutics, Inc.

$10.82+3.94%10

ALGSAligos Therapeutics Inc.

$5.02+5.68%10

SRRKScholar Rock Holding Corporation

$46.09+4.80%10

Held by ETFs

APGE is in 36 US ETFs. The largest of them, with APGE's weight in each:

Apogee Therapeutics (APGE) in two numbers

Dividend: None; No dividend in the SEC filings we hold.; Dividends
P/E: -31.12; Negative: a loss over the last twelve months. Price to free cash flow -41.78.; Financials

Questions about Apogee Therapeutics

Does Apogee Therapeutics (APGE) pay a dividend?

No. Apogee Therapeutics (APGE) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: 10-Q filed 10 Aug 2026 (period ending 30 Jun 2026), SEC. Price: last close 3 Sept 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong? Check it in APGE's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing APGE

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.